LOGO
LOGO

Corporate News

HanesBrands In Licensing Deal With G-III Apparel For Champion And C9 Champion Outerwear

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Basic apparel maker HanesBrands, Inc. (HBI) Thursday said it has entered into a strategic multi-year license agreement for Champion and C9 Champion Outerwear with G-III Apparel Group, Ltd. (GIII).

In pre-market activity on Nasdaq, G-III Apparel shares were gaining around 14.5 percent to trade at $22.10.

The deal includes design, production and distribution of outerwear for the Champion and C9 Champion brands in North America. The companies will also seek exploring opportunities across Champion's global network as a key partner.

Champion offers a full line of innovative athletic apparel for men and women, including activewear, sweats, tees, sports bras, team uniforms, footwear and accessories.

Vanessa LeFebvre, President, Global Activewear, said, "G-III's proven track record in category expansion and their best-in-class global infrastructure will enable us to reach a wider consumer base who already are, or will soon become, loyal to the Champion brand for generations. … This partnership creates a significant opportunity to leverage G-III's expertise in the outerwear category and their
diversified distribution network, which will enable us to extend our offerings and support the brand's lifestyle proposition."

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Global Economics Weekly Update -May 18 – May 22, 2026

May 22, 2026 14:46 ET
Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.

Latest Updates on COVID-19